GlobeImmune sets IPO range

GlobeImmune Inc. (Louisville, Colo.) amended its IPO and now plans to sell 5 million shares at $11-$13 per share. A $12 price would raise $60 million and value the company at $206.8 million. Wells Fargo; Piper Jaffray; JMP Securities; Needham; and MLV are underwriters. In July, GlobeImmune proposed to raise up to $69 million. ...